 |
Home | ||||||||
|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||
|
|
Our Faculty | ||||||||
|
|
|||||||||
|
|
Education | ||||||||
|
|
|||||||||
|
|
Patient Care | ||||||||
|
|
|||||||||
|
|
Research | ||||||||
|
|||||||||
|
|
|||||||||
|
|
Philanthropy/ Volunteering |
||||||||
|
|
|||||||||
|
|
Contact Us | ||||||||
Immunotherapy
Research is geared toward developing more effective immunotherapy for cancer patients, focusing on immune modulators and cell signaling pathways.
Faculty:
Michael Robertson, M.D.Research is geared toward developing more effective immunotherapy for cancer patients, focusing on immune modulators and cell signaling pathways.
Active Research Awards:
| Principal Investigator | Funding Agency | Project Title |
| Michael Robertson | NIH – National Cancer Institute | Mechanisms of STAT4 Deficiency in the Immune System of Cancer Patients |
